Pharma News

Novartis has pushed its second radioligand therapy over the FDA finish line, and the Swiss pharma has more than $2 billion in peak sales expectation linked to the new launch. ...

Digital-first patient care is a priority as Huma and AstraZeneca join forces to improve patients' lives.

Roquette is investing €25 million at its site in Lestrem, France to strengthen its position in the polyols market.

Pfizer has recalled several lots of its blood pressure drug Accuretic (quinapril HCl/hydrochlorothiazide) as well as two generic versions of the drug because of possible nitrosamine contamination....

Fujifilm is expanding its footprint within the US yet again, this time with another East Coast acquisition within driving distance of its new $2 billion headquarters. ...

Eisai and Biogen have released more data on lecanemab, another anti-Alzheimer’s drug in the partnership that spawned aducanumab. 

BioAge Labs, Inc., a biotechnology company developing medications that target the molecular causes of aging to extend healthy human lifespan, today announced that its clinical-stage oral drug BGE-...

The makers behind two of the largest COVID-19 vaccines, Pfizer, BioNTech, and Moderna, are seeking FDA approval for a fourth dose of their respective COVID-19 vaccines. Pfizer and BioNTech submitted a...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended the routine use of BioMarin’s Vimizin (elosulfase alfa) by the National Health Service (NHS) for patients with ...

On March 18, 2022, FDA approved Bristol-Myers Squibb Company’s Opdualag (nivolumab and relatlimab-rmbw) for use in adults and pediatric patients 12 years of age or older with unresectable or meta...

Marinus Pharmaceuticals, a biopharmaceutical company focused on the development of treatments for seizure disorders, announced on March 18, 2022 that FDA has approved ZTALMY (ganaxolone) for the t...

Patients eligible to receive Takeda’s Exkivity (mobocertinib) have a rare form of lung cancer that cannot be removed by surgery